Skip to content

Role of BharamgyÄ?di leha and (Ayurveda Medicine) HaridrÄ?di dhÅ«ma in the form of leha and Varti in the Management of Tamaka Å vÄ?sa.

A Comparative Clinical Study of BhÄ?raá¹?gyÄ?di leha & HaridrÄ?di dhÅ«ma in the Management of Tamaka Å?vÄ?sa.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044103
Enrollment
30
Registered
2022-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Sponsors

National Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having classical signs and symptoms of Tamaka Å?vÄ?sa (Bronchial Asthma). 2. Patient ready to give written informed consent. 3. Age group between 18-70 years of either sex.

Exclusion criteria

Exclusion criteria: 1. Age below 18 and above 70 years. 2. Patient having history of severe COPD, Emphysema, Tuberculosis, other complicated respiratory disease having any organic lesion such as tumor or any anatomical defect in airway. 3. Uncontrolled Diabetes mellitus with serious complications. 4. Uncontrolled Hypertension. 5. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Change in the Spirometry measures for Lung functions.Timepoint: at the time of screening and after completion of trial

Secondary

MeasureTime frame
1. Å?vÄ?sa ká¹?cchatÄ? (Dyspnoea) 2. PÄ«nasa (Nasal discharge) 3. KÄ?sa (Cough) 4. Kapha NiṣṭhÄ«vana(Expectoration) 5. Ghurghurakama Å?abda (Wheezing) 6. UraÅ?Å«la(Chest pain)Timepoint: at the time of screening and after completion of trial

Countries

India

Contacts

Public ContactDr Nisha Gupta

national institute of ayurveda

guptadr.nisha@gmail.com9828087640

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026